Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Clusters of comorbidities in idiopathic pulmonary fibrosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A systematic review of blood eosinophils and continued treatment with inhaled corticosteroids in patients with COPD

    Research output: Contribution to journalReviewResearchpeer-review

  2. Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Impact of the spirometric definition on comorbidities in chronic obstructive pulmonary disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. A New Pathogenic Variant of the RTEL1 Gene and Dyskeratosis Congenita: A Dermatological View

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hydroxychloroquine as a primary prophylactic agent against sars-cov-2 infection: a cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: Comorbidities are common in patients with idiopathic pulmonary fibrosis (IPF) and negatively impact health-related quality of life, health-care costs and mortality. Retrospective studies have focused on individual comorbidities, but clusters of multiple comorbidities have rarely been analysed. This study aimed to comprehensively and prospectively assess comorbidities in a multicentre, real-world cohort of patients with IPF, including prespecified conditions of special interest and to analyse clusters of comorbidities and examine characteristics, disease course and mortality of the clusters.

METHODS: Several measurements, questionnaires, medications and medical history were combined to assess comorbidities. Using self-organizing maps, clusters of comorbidities were identified and phenotypes characterized. Disease course was assessed using mixed effects models and mortality using Cox regression.

RESULTS: One-hundred and fifty IPF patients were included prospectively. All except one patient suffered from at least one comorbidity and multimorbidity was common. Arterial hypertension, gastro-oesophageal reflux disease, hypercholesterolemia, emphysema and obstructive sleep apnea were most prevalent. Four comorbidity clusters were identified. Each cluster had distinct comorbidity profiles, patient characteristics, symptom burden and disease severity. Patients with fewer comorbidities had better exercise capacity and less dyspnea at baseline, but a trend towards faster deterioration was observed. Mortality analyses showed no significant differences between clusters.

CONCLUSIONS: Multimorbidity is prevalent in patients with IPF. Four specific clusters of comorbidities may represent phenotypes in IPF. A trend towards faster decline in exercise capacity and dyspnea was observed in patients with fewer comorbidities. Increased knowledge of comorbidities facilitates prevention and treatment of comorbidities in patients with IPF.

Original languageEnglish
Article number106490
JournalRespiratory medicine
Volume185
Pages (from-to)106490
ISSN0954-6111
DOIs
Publication statusPublished - 1 Aug 2021

Bibliographical note

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

    Research areas

  • Aged, Cluster Analysis, Comorbidity, Dyspnea/epidemiology, Emphysema/epidemiology, Exercise Tolerance, Female, Gastroesophageal Reflux/epidemiology, Health Care Costs, Humans, Hypercholesterolemia/epidemiology, Hypertension/epidemiology, Idiopathic Pulmonary Fibrosis/economics, Male, Phenotype, Prevalence, Prospective Studies, Quality of Life, Sleep Apnea, Obstructive/epidemiology, Surveys and Questionnaires

ID: 74730530